Keywords: Deuterium, Metabolism, Metabolic pathway; Trimethyamine; Trimethylamine oxide;2D-CSI;DMI;2H-MRS;metabolic imaging;FMO3;Liver;disease;Mice
Motivation: The metabolite trimethylamine oxide (TMAO) is linked to multiple diseases, and there is a need for a clinically translatable tool to monitor its longitudinal formation in vivo.
Goal(s): To develop an approach to monitor quantitatively the formation of TMAO in a non-invasive manner in deep tissues of live subjects.
Approach: In vivo deuterium metabolic spectroscopy and imaging were applied to monitor and quantify the conversion of deuterium-labeled trimethylamine (TMA-d9) in the liver.
Results: The conversion of TMA-d9 to TMAO-d9 was monitored by 2H-MRS and was found to be correlated with FMO3 expression levels that are significantly higher in female compared to male mice.
Impact: The ability to monitor the TMA-d9-to-TMAO-d9 metabolism will allow us to follow, for the first time longitudinally and non-invasively, the role of TMAO in the onset and progression of multiple diseases ranging from cancer to cardiovascular disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords